Recombinant RSV vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant RSV vaccine, covering 2025-02-13 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older [Phase 2]